Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Investor Presentation
Please find enclosed herewith press release and analyst presentation on Q3FY24 and 9MFY24 earnings and business updates. Kindly take a note of the same. Alkem Laboratories Ltd - 539523 - Closure of Trading Window
The trading window shall open from 12th Feb, 24. Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30(5) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
The BOD have approved changes in KMP authorised for determining materiality under Reg 30 (5) Alkem Laboratories Ltd - 539523 - Corporate Action-Board approves Dividend
Interim dividend declared of Rs. 35 per share and pay out on and from 1st March Alkem Laboratories Ltd - 539523 - Results- Financial Results For Quarter Ended December 31, 2023
Copy of Financial Results and LRR is enclosed herewith Alkem Laboratories Ltd - 539523 - Results- Financial Results For Quarter Ended December 31, 2023
Copy of Financial Results and LRR is enclosed herewith Alkem Laboratories Ltd - 539523 - Board Meeting Outcome for Outcome Of Board Meeting Dated 09/02/2024
The Board of Directors of the Company, at its meeting held today, i.e. 09th February, 2024 have inter alia: a. Approved the Standalone and Consolidated Unaudited Financial Results for the quarter and nine months ended 31st December, 2023. b. Declared Interim Dividend of Rs. 35/- (Rupees Thirty Five only) per equity share on the face value of Rs. 2/- per share for the financial year 2023-24, pursuant to Regulation 43 read with Regulation 30 of the Listing Regulations. The meeting of the Board of Directors of the Company commenced at 11.00 a.m. and concluded at 1 p.m. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and our earlier intimation dated 01st February, 2024, we write to inform you that a conference call to discuss the Q3FY24 financial results will now be held on Friday, 09th February, 2024 at 04.30 p.m. Please find attached herewith the revised conference call details. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we write to inform you that a conference call to discuss the Q3FY24 financial results will be held on Friday, 09th February, 2024 at 04.00 p.m. Please find attached herewith the conference call details. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Corporate Action - Fixes Record Date For Interim Dividend
The record date for the purpose of payment of Interim Dividend for financial year 2023-2024 would be Saturday, 17th February, 2024, subject to declaration of the said Interim Dividend by the Board of Directors in its meeting held on 09th February, 2024. Kindly take note of the same.